Dihydrotanshinone (DHT), one of the major ingredients of Salvia miltiorrhiza Bunge (Danshen), displays many bioactivities. However, the activity and underlying mechanism of DHT in anti-inflammation have not yet been elucidated. In this study, we investigated the anti-inflammatory activity and molecular mechanism of action of DHT both in vitro and in vivo. Our data showed that DHT significantly decreased the release of inflammatory cytokines tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and IL-1β in lipopolysaccharide (LPS)-stimulated RAW264.7 cells, THP-1 cells, and bone marrow-derived macrophages (BMDMs), and altered the expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). In addition, flow cytometry results indicated that DHT reduced the calcium influx, and generation of reactive oxygen species (ROS), and nitric oxide (NO) generation in LPS-stimulated RAW264.7 cells. Moreover, DHT suppressed the transcription of nuclear factor-κB (NF-κB), the expressions of NF-κB proteins, and nuclear translocation of NF-κB/p65, thereby suggesting that the NF-κB pathway played a role in the anti-inflammatory action of DHT. In addition, DHT attenuated LPSchallenged activator protein-1 (AP-1) activity, resulting from interference of the mitogen-activated protein kinase (MAPK) pathway. The molecular docking simulation of DHT to toll-like receptor 4 (TLR4) suggested that DHT binds to the active sites of TLR4 to block TLR4 dimerization, which was further corroborated by cellular thermal shift assay and co-immunoprecipitation (Co-IP) experiments. Furthermore, the recruitment of myeloid differentiation primary response gene 88 (MyD88) and the expression of transforming growth factor-b (TGF-b)-activated kinase 1 (p-TAK1) were disturbed by the inhibition of TLR4 dimerization. Thus, investigating the molecular mechanism of DHT indicated that TLR4-MyD88-NF-κB/MAPK signaling cascades were involved in the anti-inflammatory activity of DHT in vitro. In in vivo mouse models, DHT significantly ameliorated LPS-challenged acute kidney injury, inhibited dimethylbenzene-induced mouse ear oedema, and rescued LPS-induced sepsis in mice. Taken together, our results indicated that DHT exhibited significant anti-inflammatory activity both in vitro and in vivo, suggesting that DHT may be a potential therapeutic agent for inflammatory diseases.
Introduction
Macrophages, a product of blood monocytes, are specialized cells that can engulf and digest bacteria or other harmful organisms. Macrophages can bring antigens to T cells to initiate inflammation by releasing pro-inflammatory cytokines, such as interleukin-6 (IL-6), IL-1, and tumor necrosis factor-α (TNF-α) [1, 2] . In addition, macrophages generate reactive oxygen species (ROS) and nitric oxide (NO) to eliminate bacteria during inflammatory processes. Macrophages can be classified into M1 (classically activated macrophages) and M2 (alternatively activated macrophages) [3] .
M1 macrophages exhibit the unique ability to express transcriptional factors, including NF-κB, AP-1, and signal transducers and activators of transcription 1 (STAT1), all of which initiate inflammation. However, M2 macrophages barely express those factors and decrease inflammation [4] . Ever since the first Toll-like receptor (TLR) member, named TLR4, was identified in drosophila, 15 TLRs have since been unraveled [5] . When activated by LPS, TLR4 will dimerize to mediate NF-κB and/or MAPK signaling pathways through interacting between dimerized TLR4 and its downstream 'bridging adaptor' molecule MyD88 [6, 7] . MyD88 is recruited to TLR4 through its interaction with the Toll/IL-1 receptor (TIR) domain of TLR4, which sequentially recruits or activates the following molecules involved in the cascade: interleukin receptor-associated kinase 1/4 (IRAK1/4), toll-interleukin 1 receptor (TIR) domain containing adaptor protein (TIRAP), TNF receptor-associated factor-6 (TRAF6), and transforming growth factor-b (TGF-b)-activated kinase 1 (TAK1) [8] . TAK1 subsequently leads to signaling through NF-κB and/or the mitogen-activated protein kinase (MAPK) pathway to translocate, synthesize, and release pro-inflammatory mediators [9, 10] . Therefore, suppressing the formation of TLR4 dimers may be an alternative strategy to treat inflammatory disorders.
Danshen is widely used in traditional Chinese medicine for the treatment of many diseases [11] . Tanshinone capsules and Fu Fang Danshen dripping pills, which were employed to treat inflammatory diseases and cardiovascular diseases, respectively, have been approved by the China Food and Drug Administration. Specifically, in the United States, Fu Fang Danshen dripping pills have been approved for phase 3 clinical trials by the Food and Drug Administration (FDA). Many major constituents of Danshen, such as tanshinone IIA and cryptotanshinone, have been corroborated to show anti-inflammatory effects [11, 12] . However, only few studies have been performed on the anti-inflammatory effects and mechanisms of action of dihydrotanshinone (DHT), an analog of tanshinone IIA. Therefore, in the present study, we investigated the anti-inflammatory effects and underlying mechanisms of action of DHT both in vitro and in vivo.
Materials and methods

Regents
The purity of DHT (over 98%) that was isolated from Danshen in our laboratory was determined by high-performance liquid chromatography-evaporative light scattering detector (HPLC-ELSD). Griess reagent (modified-G4410), Lipopolysaccharides from Escherichia coli O111:B4, granulocyte-macrophage-colony-stimulating factor (GM-CSF), 2′,7′-Dichlorodihydrofluorescein diacetate (DCFH 2 -DA), and 1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA-AM) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco's modified eagle medium (DMEM), Roswell park memorial institute-1640 medium (RPMI 1640), and fetal bovine serum (FBS) were obtained from Life Technologies/Gibco Laboratories (Grand Island, NY, USA). ELISA kits were obtained from Neobioscience (Shenzhen, China). Antibodies: the NF-κB pathway sampler kit (#9936), iNOS (#13120), HA (#5017), Flag (#14793), COX-2 (#4842), the MAPK pathway sampler kit (#9926), TAK1 (#5206), p-TAK1 (#9939), MyD88 (#4283), the phospho-MAPK pathway sampler kit (#9910), and TLR4 (#14358) were obtained from Cell Signaling Technologies (Beverly, MA, USA). HA-tag magnetic IP/Co-IP kit, turbofect transfection regent (R0531), Fluo-3/AM, NO detector DAF-FM, and protein A/G magnetic beads kit were obtained from Life Technologies (Waltham, MA, USA). Dual-Glo luciferase assay system kit and qRT-PCR kit were purchased from Promega (Madison, WI, USA).
Cell culture
RAW264.7 macrophages and HEK 293T cells were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and American Type Culture Collection (ATCC, Manassas, VA, USA), respectively. They were cultured in DMEM with 10% FBS. THP-1 cells, a gift from Dr. Li-Juan Liu (University of Macau), were cultured in RPIM 1640 with 10%FBS. Cells were maintained at 37°C under a humidified atmosphere of 5% CO 2 in an incubator.
MTT assay
Cells were cultured in 96-well plates at a density of 5 × 10 4 overnight, which were subsequently treated with indicated compounds for 24 h. MTT was employed to detected compounds' cytotoxicity as previously reported [13] .
BMDMs
Primary BMDMs were isolated from BALB/c mice as reported previously [14] . Briefly, mouse bone marrow cells were harvested and cultured in DMEM supplemented with 10% FBS and 20% M-CSF-conditioned medium from L929 cells for 7 days. Flow cytometry assays were employed to determine the purity of BMDMs.
Griess reagent assay
RAW264.7 cells or THP-1 cells were seeded in 12-well plates at a density of 2 × 10 5 and cultured overnight. Cells were pretreated with DHT (2, 4, 8 μM) for 1 h, then cells were treated with LPS (1 μg/mL) for another 24 h. The medium was collected to determine the nitrite level.
Assessment of cytokine release
TNF-α, IL-6, and IL-1β were investigated by ELISA following the instructions of the manufacturer. Cells were plated into 24-well plates overnight. Pretreated with DHT (2, 4, 8 μM) for 1 h, DHT and LPS (1 μg/ mL) were cultured for 12 h. The medium was determined for the determination of the cytokines release.
Flow cytometry assay
RAW264.7 cells were seeded in 12-well plates at a density of 2 × 10 5 cells per well and cultured overnight. Subsequently, cells were pretreated with DHT (2, 4, 8 μM) for 1 h, after which LPS (1 μg/mL) was added for another 6 h. Then, treated cells were harvested and loaded with DAF-FM (1 μM, 1 h), DCFH 2 -DA (1 μM, 30 min), or Fluo-3/AM (5 μM, 30 min), and flow cytometry was performed using the FITC channel using a FACScan Flow cytometer (Becton-Dickinson, Oxford, UK).
Immunofluorescence assay
Translocation of NF-κB/p65 from the cellular cytoplasm to the nucleus was evaluated by immunofluorescence assay as previously reported [15] . In brief, RAW264.7 cells were seeded at a density of 2 × 10 5 cells into a confocal dish (SPL, Pocheon, Korea) and cultured overnight. Next, cells were pretreated with DHT (8 μM) for 1 h, then R. Yuan, et al. Pharmacological Research 142 (2019) [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] cells were stimulated with LPS (1 μg/mL) for another 2 h. Images were taken using a Leica TCS SP8 laser confocal microscope (Leica, Wetzlar, Germany) at an excitation/emission wavelength of 588/615-690 nm.
Transient transfection and luciferase assay
For the luciferase assay, BMDMs were seeded in 96-well plates at a density of 2 × 10 4 per well and were transiently co-transfected with piNOS-luc/pRL-TK, pNF-κB-luc/pRL-TK, or pAP-1-luc/pRL-TK plasmids, respectively. As a reference control, the pRL-TK plasmid was used. In brief, plasmids (0.1 μg/well) with Turbefect transfection regent (0.2 μL/well) were stored for 15-20 min at room temperature to form an active complex. Then, the complex was added to the cells and after 48 h, cells were pretreated with DHT for 1 h and stimulated with LPS for another 24 h. Subsequently, the luciferase activity was determined using a Dual-Glo luciferase assay system kit according to the manufacturer's instructions.
Co-immunoprecipitation assay
RAW264.7 cells were seeded into a dish at a density of 4 × 10 6 were seeded and cultured overnight. Cells were pretreated with DHT (8 μM) for 1 h, and then stimulated with LPS (1 μg/mL) for another 12 h. Total proteins were harvested using IP lysis buffer. Proteins (600 μg) were immunoprecipitated using protein A/G magnetic beads. The subsequent steps were performed according to the manufacturer's instructions. An equivalent amount of each protein sample was subjected to SDS-PAGE gel electrophoresis and transferred to polyvinylidene fluoride (PVDF) membranes. Immunoblotting analysis was conducted following Western blot analysis (see section below).
Western blotting analysis
Cell lysis buffer configuration, protein collection and concentration examination, electrophoresis, SDS-page, and immunoblotting were performed as described previously [13] . The primary antibodies and secondary antibodies used were diluted 1000-fold or 10000-fold, respectively. Chemiluminescence intensity was visualized using Super Signal™ West Femto Maximum Sensitivity Substrate (ThermoFisher, Waltham, MA, USA), using a ChemiDoc™ MP Imaging System (Bio-Rad, Hercules, CA, USA).
TLR4 dimer formation
HEK293 T cells were seeded at a density of 4 × 10 5 cells into a 10 cm dish, and cultured overnight. HA-TLR4 (3 μg) and Flag-TLR4 (3 μg) plasmids obtained from Addgene (Watertown, Massachusetts, USA) were co-transfected using Turbofect transfection reagents for 24 h following the manufacturer's instructions. The transfected cells were harvested and plated into a dish (5 cm i.d.) at a density of 4 × 10 5 cells and cultured overnight. Next, cells were pretreated with DHT (8 μM) for 1 h, and cells were stimulated with LPS (1 μg/mL) for another 12 h. Cells were harvested using IP lysis buffer and the formation of TLR4 dimer was determined using anti-HA magnetic beads and Western blot analysis.
Cellular thermal shift assay
RAW264.7 cells were seeded into a dish (2 × 10 6 cells) overnight.
Treated with DHT (8 μM) for 12 h, cells were lysed by RIPA and total proteins were collected. Then, proteins were equally divided into 6 parts, which were heated at 44, 48, 52, 56, 60, and 64 ℃ for 3 min, respectively. The corresponding loading buffer was added into the proteins that were analyzed by western blotting.
Docking to TLR4 complex
A docking model of DHT with the TLR4 complex (PDB code: 3 FXI) was performed using the molecular modeling packages in Ledock (http://www.lephar.com). Crystal structures of the TLR4 complex were obtained from the RCSB Protein Data Bank (PDB code: 3 FXI) [16] .
Quantitative real-time PCR (qRT-PCR) assay
RAW264.7 cells were seeded at a density of 2 × 10 6 cells into a dish and cultured overnight. Cells were pretreated with DHT (8 μM) for 1 h, then cells were stimulated with LPS (1 μg/mL) for another 2 h. Total RNA was extracted using a Trizol assay kit. Subsequently, RNA (1 μg) was subjected to qRT-PCR using a qPCR master mix kit (Promega, Madison, Wisconsin, USA). PCR amplification was performed by incorporating SYBR green. The oligonucleotide primers for mouse iNOS, COX-2, TNF-α, IL-6, IL-1β, and GAPDH were synthesized by KeyGEN BioTECH (Jiangsu, China), and gene sequences were as follows: iNOS-F: GGCAGCCTGTGAGACCTTTG, iNOS-R: GCATTGGAAGTGAAGCGTTTC, COX-2-F: TGAGTACCGCAAACGCTTCTC, COX-2-R: GTGTAATTAAGCC TCCGACTTG, TNF-α-F: TTCTGTCTACTGAACTTCGGGGTGATCGGTCC, TNF-α-R: GTATGAGATAGCAAATCGGCTGACGGTGTGGG, IL-6-F: TCC AGTTGCCTTC TTGGGAC, IL-6-R: GTGTAATTAAGCCTCCGACTTG, IL-1β-F GAAAGACGG CACACCCACCCT, IL-1β-R GCTCTGCTTGTGAGGT GCTGATGTA, GAPDH-F: CATGACCACAGTCCATGCCATCAC, and GAPDH-R: TGAGGTCCACCACCC TGTTGCTGT.
Animals and experimental design
All animal studies were approved by the Ethics Committee of the Experimental Animal Centre of Soochow University (Suzhou, China, No. IACUC2017-12). Animal experiments performed in this study were in agreement with the Local Guide for the Care and Use of Laboratory Animals. Male BALB/C mice were housed under standard specific pathogen-free (SPF) conditions with a controlled temperature (25℃) and humidity (50%).
For the AKI model [17] , LPS-induced mice (males, 6-8 weeks, 20 ± 2 g) were randomly divided into a normal group, DHT treatment groups (10, 20, and 40 mg/kg, i.p.), an LPS group (10 mg/kg, i.p.), and a positive control dexamethasone (5 mg/kg, i.p.) group. Prior to the LPS injection, mice were pretreated with DHT for 2 h, and 4 h after the LPS injection, mice were administrated with DHT again for another 8 h. Then, blood was harvested and serum was prepared for the determination of cytokines.
For the dimethylbenzene (DTB)-induced mouse ear oedema model [18] , mice (males, 6-8 weeks, 20 ± 2 g) were randomly divided into four groups: a control group, DHT treatment groups (10, 20, and 40 mg/kg) and a DTB group (40 μL). Mice were pretreated with DHT for 2 h, then DTB was applied to the surface of the right ear. Two hours later, mice were sacrificed by cervical dislocation, and ear punches (7 mm, i.d.) were collected and weighed. Oedema was determined by the increased weight of the right ear punches versus those of the left ear.
LPS-induced sepsis mice (males, 6-8 weeks, 20 ± 2 g) were randomly divided into four groups: a control group, LPS group (20 mg/kg, i.p.), DHT treatment group (40 mg/kg), and a positive control dexamethasone (5 mg/kg, i.p.) group. Prior to the LPS injection, mice were pretreated with DHT for 2 h, then 4 h after the LPS injection, mice were administrated with DHT for a second time. Mice were continuously observing and the survival was recorded for 132 h. Remaining mice were sacrificed by cervical dislocation.
Histopathological examination
Mouse tissues were fixed with 10% formaldehyde buffer for over 24 h. After dehydration, tissues were embedded in paraffin, sections R. Yuan, et al. Pharmacological Research 142 (2019) [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] were cut, and stained with hematoxylin and eosin (H&E). Pathological changes were observed and recorded using a light microscope.
Data analysis
All results were repeated at least three independent times and presented as means ± SD. The significance of the intergroup differences was analyzed with the one-way analysis of variance (one-way-ANOVA) and Dunn´s multiple comparison tests using GraphPad Prism 6.0 software. p < 0.05 was considered as the significant difference.
Results
DHT exhibited a better anti-inflammatory effect
As it stands now, a deluge of tanshinones were isolated and purified from Danshen. DHT, tanshinone I (TNI), cryptotanshinone (CPT), and tanshinone IIA (TNA) are major constituents of Danshen (Fig. 1A) , which has been shown to exhibit many bioactivities [19] . Due to their similar structures, the activity of DHT, TNI, CPT, and TNA has been screened in this study. Using LPS-stimulated RAW264.7 cells, the antiinflammatory activity of DHT, TNI, CPT, and TNA was investigated. As R. Yuan, et al. Pharmacological Research 142 (2019) [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] shown in Fig. 1B -D, DHT exhibited better inhibitory activities of the nitrite level and NO release when compared to that of TNI, CPT, and TNA. Therefore, DHT was chosen as an anti-inflammatory agent for further studies. None of the four compounds tested showed cytotoxicity at the maximum dosage of 8 μM (Fig. 1E ).
DHT decreased inflammatory response in macrophages
In general, inflammatory signal messengers, such as NO, nitrite level, iNOS, and COX-2 are initially investigated due to their significant changes in many inflammatory models [20, 21] . Ca 2+ is also an important inflammatory response signal, and so are ROS [22, 23] . As shown in Fig. 2A , DHT inhibited LPS-induced nitrite levels in a concentration-dependent manner. Using the flow cytometry assay, NO release was determined by DAF-FM. Our results indicated that DHT significantly suppressed NO release in a concentration-dependent manner ( Fig. 2B and C) . Furthermore, the microscope images indicated that DHT decreased LPS-induced NO fluorescence intensity (Fig. s1 A) . Similar to the effect of N-Acetyl-L-cysteine (NAC) and L-Glutathione reduced (GSH), DHT significantly reduced ROS generation in RAW264.7 cells as shown by flow cytometry analysis, which was further confirmed by using a MAK-143 intracellular ROS kit (Sigma, St. Louis, MO, USA) ( Fig. 2D and E) and the microscope images (Fig. s1B) . The Fluo3-AM/ ester was employed to determine the intracellular calcium concentration. Using flow cytometry, we found that DHT inhibited LPSinduced intracellular calcium increase in a dose-dependent manner (Fig. 2F) , which was further confirmed by microscope imagines (Fig.  s1C) . In addition, DHT inhibited COX-2 and iNOS protein expression in RAW264.7 cells in a concentration-dependent manner (Fig. 2G) . The findings were further validated by mRNA expression levels (Fig. 2H ).
Using both a reporter gene assay and a luciferase activity assay, we determined that DHT significantly suppressed LPS-induced iNOS promoter activity in a concentration-dependent manner in BMDMs (Fig. 2I) . Collectively, these data indicated that DHT suppressed inflammatory responses in BMDMs.
DHT inhibited LPS-induced release of pro-inflammatory cytokines
In addition to NO, calcium, and ROS levels, also TNF-α, IL-6, and IL-1β will be released in LPS-stimulated macrophages via the NF-κB pathway and/or MAPK pathway [2, 24] . In this study, we showed by ELISA that DHT significantly decreased TNF-α and IL-6 levels in LPSstimulated RAW264.7 cells in a concentration-dependent manner (Fig. 3A and D) . The inhibitory effect of DHT on TNF-α, IL-6, and IL-1β release was further validated in BMDMs and THP-1 cells (Fig. 3B, C , E-H). In addition, mRNA expression levels of TNF-α, IL-6, and IL-1β were significantly decreased after DHT treatment of RAW264.7 cells (Fig. 3I) . Taken together, these data showed that DHT effectively (Fig. 3C, F , H) BMDMs were pretreated with DHT for 1 h before being stimulated with LPS (0.2 μg/mL) for 24 h. Supernatants were collected and pro-inflammatory cytokines, such as TNF-α, IL-6, and IL-1β, were determined by ELISA. (I) RAW264.7 cells pretreated with DHT were stimulated with LPS for 4 h. mRNA levels of TNF-α, IL-6, and IL-1β were determined using qRT-PCR as described in the Methods section. * P < 0.05, ** P < 0.01, *** P < 0.001 when compared to the LPS alone group.
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inhibited TNF-α, IL-6, and IL-1β release as well as mRNA expression.
DHT suppressed the NF-κB and AP-1 activation in LPS-stimulated macrophages
The transcriptional factors NF-κB and AP-1 play a pivotal role in LPS-induced inflammatory processes [25] . Using transient transfection and reporter gene assays in BMDMs, we showed that DHT significantly inhibited LPS-induced NF-κB-dependent luciferase activity and AP-1 luciferase activity in a concentration-dependent manner (Fig. 4A and  B) . In addition, LPS dramatically increased p-p65, which was suppressed by DHT in RAW264.7 cells (Fig. 4C) . Furthermore, in LPS-stimulated RAW264.7 cells, immunofluorescence analysis indicated that DHT suppressed the translocation of NF-κB/p65 into the nucleus (Fig. 4D) .
NF-κB and MAPKs pathways were involved in DHT's antiinflammatory process
In addition to NF-κB activity and translocation, DHT also exerted an important effect on the NF-κB pathway. As shown in Fig. 5A , LPS-induced IκB-α phosphorylation and degradation were inhibited by DHT pretreatment of RAW264.7 cells. Next, the expression of IKK-α and IKK-β, two upstream kinases of IκB in the NF-κB signal pathway, was determined. Our data showed that DHT significantly suppressed LPS-induced IKK-α/β phosphorylation without affecting the total IKK-α/β Fig. 4 . Effects of dihydrotanshinone on lipopolysaccharide-stimulated NF-κB and AP-1 activation. (A, B) Bone marrow-derived macrophages (BMDMs) were transiently co-transfected with NF-κB-luc and TK-luc or AP-1-luc and TK-luc for 24 h. Cells were pretreated with dihydrotanshinone (DHT) before being stimulated with LPS for 24 h. The luciferase activity was determined using a Dual-Glo luciferase assay. (C) RAW264.7 cells pretreated with DHT for 1 h were stimulated with LPS for 4 h. The expression of phosphorylated p65 was determined by Western blot analysis. (D) RAW264.7 cells pretreated with DHT for 1 h were stimulated with LPS for 2 h. P65 translocation was determined using immunofluorescence analysis. * P < 0.05, ** P < 0.01, *** P < 0.001 when compared to the LPS alone group. Scale bar: 20 μM.
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expression. Activation of the MAPK (JNK1/2, ERK1/2, and p38MAPK) signaling pathways is always a response to inflammatory stress [26] .
Furthermore, phosphorylation of MAPK activates c-Jun, thereby resulting in its translocation into the nucleus, and its binding with Jun or Fos family members to form the AP-1 transcriptional factor [27] . To R. Yuan, et al. Pharmacological Research 142 (2019) [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] determine the effect of DHT on the MAPK signaling pathway, the expression of JNK1/2, ERK1/2, and p38 MAPK was determined using Western blot analysis. As shown in Fig. 5B , DHT pretreatment significantly suppressed p-JNK1/2, p-ERK1/2, and p-p38 MAPK expression levels in a concentration-dependent manner, however, total JNK1/ 2, ERK1/2, and p38 MAPK expression were unaltered. Thus, these findings showed that the MAPK and NF-κB pathways might participate in the anti-inflammatory activity of DHT.
DHT blocked TLR4 dimerization
TLR4, a transmembrane receptor located on the surface of many cells, plays a pivotal role in inflammatory processes [28] . The combination of LPS and MD2 will cause TLR4 to form a dimer, which then modulates NF-κB and/or MAPK signaling pathways, thereby spawning a pathogen-specific innate immune response through the release of proinflammatory cytokines [29] . To explore the effect of DHT on the TLR4 dimerization, we employed TLR4-HA and TLR4-Flag plasmids to cotransfect HEK293 T cells, and to determine the precipitation of TLR4-Flag and TLR4-HA using CO-IP assays. As shown in Fig. 5C , DHT significantly decreased the precipitation of TLR4-Flag pulled down by TLR4-HA, which indicating that DHT disrupted LPS-induced TLR4 dimerization. In addition, cellular thermal shift assay indicated that TLR4 proteins pretreated with DHT were more stable than that pretreated with DMSO at various temperature, suggesting that DHT bound to TLR4 (Fig. s2) . Furthermore, molecular docking assays showed that DHT was buried in the pocket of the TLR4-MD-2 complex (Fig. 5F ) and interacted with several amino acids sites including ILE94.C, ILE63.C, ILE46.C, PHE76.C, and LEU74.C, which occupied the space and weakened the binding of LPS with TLR4-MD-2. Together, our data showed that DHT effectively disturbed TLR4 dimerization.
DHT exerted anti-inflammatory activity involved in MyD88-TAK1 signaling cascades
MyD88, a downstream protein of TLR4, is recruited by TLR4 dimerization and will phosphate TAK1 to activate NF-κB and MAPK pathways [30] . TAK242, a specific inhibitor of TLR4, was employed to explore whether TLR4 mediated the NF-κB and MAPK pathways. In the present study, similar to DHT, TAK242 decreased LPS-induced expressions of p-p65, p-JNK1/2, p-ERK1/2, and p-p38 (Figs. s3 A and s3B) . Using Co-IP assays, we showed that DHT significantly suppressed LPSinduced complex formation of TLR4 and MyD88 (Fig. 5D ). In addition, DHT inhibited LPS-induced phosphorylation of TAK1 without altering total TAK1 levels (Fig. 5E ). Taken together, MyD88/TAK1 signaling cascades were involved in anti-inflammatory processes of DHT.
DHT rescued death from septic shock and suppressed dimethylbenzeneinduced ear oedema
In our previous study, we showed that tanshinones exhibited a significant anti-inflammatory activity [19] . However, DHT, one of the major constituents of Danshen, has not been studied and little is known about its anti-inflammatory effects and underlying mechanism of action. In the present study, we investigated the anti-inflammatory activity of DHT in vivo and in vitro. Sepsis, a clinical syndrome caused by injury or infection, is characterized by a whole-body inflammatory response [31, 32] . As shown in Fig. 6A , all LPS-induced sepsis mice died within 72 h. However, pretreatment with DHT for 1 h significantly increased the survival rate (50%) at 132 h, which was more effective than that of DEX (20%). Dimethylbenzene (DTB) is often employed to induce an acute inflammatory response in animal models, which results in ear oedema when administrated to the surfaces of the ear [19] . Regarding the advantages of DTB-induced ear oedema in mice, the anti-inflammatory model is employed to evaluate the treatment effect for drug screenings. In our study, DHT significantly inhibited DTB-induced ear oedema (Fig. s4 A) . In addition, H&E staining of ear sections indicated that DHT decreased DTB-induced oedema, cell necrosis, and lymphocytic infiltration (Figs. s4B and s4C) .
DHT rescued LPS-induced AKI in mice
AKI involves an abrupt or rapid loss of kidney function [15, 17] , leading to an increase in serum creatinine and urine level due to reduced urine output [33] . In previous studies, LPS has been identified as one of the most important factors leading to AKI [34] . LPS upregulated the production of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β, which led to the development of AKI [35, 36] . In this study, DHT significantly rescued mouse kidney function and decreased LPS-induced urine and creatinine levels as well as levels of TNF-α, IL-6, and IL-1β (Figs.7A-7E ). As shown in Fig. 7F and G, for the control group, H&E staining showed normal kidney tubules. However, for the LPS-challenged mouse, renal lesions marked the oedema of renal tubular epithelial cells, renal interstitial oedema of epithelial cells, and leukocyte infiltration was significantly observed. DHT pretreatment significantly attenuated LPS-induced epithelial atrophy and necrosis and interstitial oedema. DEX was used as the positive control. Thus, DHT exhibited a significant effect on LPS-induced AKI.
Discussion
For LPS-stimulated macrophages, nitric oxide synthases, specifically, inducible nitric oxide synthase (iNOS) will be overexpressed, spawning a large amount of NO release to activate diverse of immunepathological pathways [37, 38] . COX-2, a crucial enzyme that modulates the generation of prostaglandins and other pro-inflammatory cytokines, including TNF-α, IL-6, and IL-1β will be released during inflammatory processes [39] . In this study, in terms of nitrite level, we found that DHT exhibited the most significant activity. Tanshinone IIA and cryptotanshinone almost displayed a similar activity, which was better than the one of tanshinone I. It suggested that unsaturated D ring played an important role on an anti-inflammatory activity. When D ring is saturated, unsaturated A ring played an important role. However, methyl groups were not important for their activities. In addition, DHT significantly suppressed iNOS expression and TNF-α, IL-6, NO, and IL-1β release in LPS-stimulated macrophages without altering the expression of COX-2.
In macrophages, calcium, as a second signal messenger, plays an important role in the activation of macrophages, such as transcriptional control, and the activation of kinases, and phosphatases. [40] . An increase in intracellular Ca 2+ in accordance with LPS stimulation has been shown to be involved in the inflammatory process for the R. Yuan, et al. Pharmacological Research 142 (2019) [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] transcriptional activation, and leads to TNF-α, IL-6, IL-1β, and NO release [40] . In this study, DHT was found to remarkably decrease LPSinduced calcium overload in RAW264.7 cells. In previous studies, it has been demonstrated that DHT exhibited cardiovascular protection via suppressing ROS generation in animal models [41, 42] . In LPS-stimulated RAW264.7 cells, DHT was found to remarkably decrease LPS-induced ROS generation in RAW264.7 cells similar to ROS scavenger NAC and GSH. The NF-κB pathway is often activated in LPS-treated macrophages [43] . NF-κB is composed of p65, p50, and IκB is activated by the degradation and phosphorylation of IκB via phosphorylating of IκB kinase [44] . Activated p65/p50 in the cytoplasm translocates into the nucleus to activate transcriptional factors, such as AP-1, and iNOS [45] . DHT dramatically suppressed LPS-induced phosphorylation of IKKα/β, IκBα, and p65, degradation of IκBα, luciferase activity p65 and AP-1, and the translocation of p65 into the nucleus. The MAPKs (JNK1/2, p38, and ERK1/2) pathway also participates in regulating inflammatory processes in LPS-stimulated macrophages. In this study, we demonstrated that DHT significantly decreased the phosphorylation of JNK1/2, ERK1/2, and p38 without altering total JNK1/2, ERK1/2, and p38 in LPS-stimulated RAW264.7 cells. Collectively, the NF-κB and MAPKs pathways both participate in anti-inflammatory processes of DHT.
Presently, at least 15 TLR family members have been identified, of which 11 TLRs have been found in humans [28] . Specifically, TLR4 was the first pattern-recognition receptor (PRR) that was identified among TLR family members [28] . In the previous study, TLR4 in association with MD-2 is responsible for the physiological recognition of LPS in many different cells that express TLR4 and MD-2, such as macrophage, lymphoid cells, epithelial, endothelial and vascular smooth-muscle cells [46] . TLR4 and MD-2 form a heterodimer that recognizes a common 'pattern' in structurally diverse LPS molecules [16] . When LPS is released from the bacterial membrane, it will be captured by the TLR4-MD-2 heterodimer that has complex ligand specificity, through two accessory proteins: LPS-binding protein and CD14 [47] . Subsequently, the receptor multimer is formed, including two copies of the TLR4-MD-2-LPS complex displayed in a symmetrical manner to activate pro-inflammatory signaling pathways [16] . TLR4 and MD-2 form a heterodimer that recognizes a common 'pattern' in structurally diverse LPS molecules [16] . Thus, when DHT bound to TLR4 or blocked the combination of TLR4 and MD-2, it will inhibit TLR4 dimer formation, which may be an alternative strategy to treat inflammatory disorders. Here, cellular thermal shift assay indicated that DHT bound to TLR4, which blocked TLR4 dimer. Additionally, two different plasmids TLR4-HA and TLR4-Flag were used, and our data showed that DHT significantly suppressed the precipitation of TLR4-HA and TLR4-Flag. Furthermore, our docking results indicated that DHT competitively bound to the active sites of TLR4 and MD2 that initially bind to LPS. Activated TLR4 will recruit MyD88 and/or TIR-domain-containing R. Yuan, et al. Pharmacological Research 142 (2019) [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] adapter-inducing interferon-β (TRIF) through TRIF-related adaptor molecule (TRAM) that are considered 'bridging adaptors' for binding to TLR4, respectively [28] . Of the two proteins, the MyD88 is often needed to activate the NF-κB pathway and/or the MAPK pathway during inflammatory processes [29] . In the present study, the TLR4-MyD88 pathway was investigated, and our data indicated that DHT significantly decreased the precipitation of TLR4 and MyD88 in LPS-stimulated RAW264.7 cells. The downstream signal proteins of TLR4-MyD88 comprised of TAK1, TAB1, and TAB2 [9, 29] . Functionally, TAB1 activates the kinase activity of TAK1 and TAB2, an adaptor to link TAK1 with TRAF, which facilitates TAK1 pathways. Furthermore, as a major member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family, TAK1 is considered to be necessary for NF-κB and AP-1 activations [30] . Our data indicated that DHT suppressed LPSinduced phosphorylation of TAK1 without effecting total TAK1 in RAW264.7 cells, thereby suggesting that TAK1 participated in the TLR4-MyD88 pathway. In summary, and as shown in Fig. 8 , our data demonstrated that DHT exhibited anti-inflammatory activity through blocking TLR4 dimerization. When recruiting MyD88 to activate TAK1, DHT decreased calcium exclusion, ROS generation, and pro-inflammatory cytokine release through NF-kB and MAPK pathways.
To further confirm the anti-inflammatory effects of DHT, three different types of animal models like LPS-induced septic mice, dimethylbenzene-induced mouse ear oedema, and LPS-induced AKI models were employed in our study. Dimethylbenzene-induced immunity responses are often dependent on TLR4, in which the prolonged inflammatory process leads to systemic inflammatory syndromes, such as oedema and sepsis [48, 49] . In our study, we showed that DHT inhibited dimethylbenzene-induced ear oedema, thereby suggesting that DHT decreased acute inflammation. Furthermore, DHT had a protective effect on LPS-induced sepsis in mice. Our findings showed that pretreatment with DHT alleviated the release of cytokines, such as IL-1β, IL-6, and TNF-α. AKI, a condition in which kidney function is abruptly or rapidly lost, leads to an increase in serum creatinine and urine concentration due to a lower output of urine. AKI caused by aberrant inflammatory responses often leads to death [17, 35] . In previous studies, it has been shown that LPS is an effective agent that leads to AKI in mice [17] . In this study, we demonstrated that induction with LPS upregulated the production of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β as well as the levels of blood urine and creatinine in mice, respectively. Pretreatment with DHT significantly rescued mouse kidney function and attenuated LPS-induced BUN, serum creatinine, TNF-α, IL-6, and IL-1β. H&E staining indicated that DHT significantly ameliorated AKI in a dose-dependent manner. Although the effect of DHT on AKI was corroborated, further detailed mechanisms on AKI remains to be investigated.
Conclusions
In summary, our data indicated that DHT displays its anti-inflammatory effects through NF-κB and MAPKs pathways via blocking TLR4 dimerization that is involved in MyD88 signal cascades. These underlying mechanisms of DHT were thought to contribute to its capability to decrease DTB-induced ear oedema, increase the survival of LPS-induced sepsis mice, and ameliorate LPS-induced AKI. Collectively, our data show that DHT has the potential to develop into a novel agent for the treatment of inflammatory diseases. 
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The authors declare no competing conflict of interests. Fig. 8 . The schematic of the anti-inflammatory activities of dihydrotanshinone in vitro. Dihydrotanshinone (DHT) blocks TLR4 dimerization to recruit MyD88 and activate TAK1, which decreases calcium exclusion, reactive oxygen species (ROS) generation, and the release of pro-inflammatory cytokines through NFkB and MAPK pathways. LPS, lipopolysaccharides; TLR4, toll-like receptor 4; TNF-α, tumor necrosis factor-α; NO, nitric oxide; COX-2, cyclooxygenase-2; iNOS, inducible nitric oxide synthase; NF-κB, nuclear factor-κB; AP-1, activator protein-1; IL-1β, interleukin-1β; IL-6, interleukin-6; MAPK, mitogen-activated protein kinase; JNK, c-Jun N-terminal kinase; ERK, extracellular regulated protein kinase; MyD88, myeloid differentiation primary response gene 88; TAK1, transforming growth factor-b (TGF-b)-activated kinase 1; ROS, reactive oxygen species.
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